Stem Cell Businesses and Right to Try Laws

Douglas Sipp, Leigh Turner, John E.J. Rasko

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)304-305
Number of pages2
JournalCell Stem Cell
Issue number3
StatePublished - Sep 5 2019

Bibliographical note

Funding Information:
On a pro bono basis, L.T. submitted an expert opinion report supporting claims of plaintiffs in litigation filed against the Lung Institute's Florida clinic. J.E.J.R. has received honoraria or speaker's fees from GSK, Takeda, Gilead, Cynata, Pfizer, Spark, Novartis, Celgene, and bluebird bio; owned stock in Genea and serves as Director of Pathology; and received equity in Rarecyte in lieu of fees.

Cite this